OOIR: Observatory of International Research

Papers

(The TQCC of Vascular Pharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107	105
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran	99
Graphical abstract TOC	48
Biobanks: The unmet need in heart failure management	38
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients	34
Graphical abstract TOC	34
Thromboprophylaxis strategies to improve the prognosis of COVID-19	33
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis	27
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies	23
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study	23
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease	23
Editorial Board	23
Animal experimental models of ischemic limbs – A systematic review	23
A random shuffle method to expand a narrow dataset: A heart failure cohort example	22
Exploiting endothelial functions in bone regenerative medicine	21
Prevention of cardiovascular complications in elderly cancer patients	20
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes	20
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration	20
Editorial Board	19
Editorial Board	19
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets	18
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis	18
Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model	17
MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension	17
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease	17

Diabetic neuropathy: Molecular approach a treatment opportunity	16
Adipsin in the pathogenesis of cardiovascular diseases	16
Diabetes and vascular disease: New therapeutic avenues	16
Global and endothelial G-protein coupled receptor 75 (GPR75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension	16
Interaction of FOXO1 and SUMOylated PPARγ1 induced by hyperlipidemia and hyperglycemia favors vascular endothelial insulin resistance and dysfunction	16
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention	15
Deleterious effects of levamisole, a cocaine adulterant, in rabbit aorta	15
Graphical abstract TOC	15
The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies	15
Graphical abstract TOC	14
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro	14
Circulating osteonectin predicts postural imbalance and cardiac dysfunction in heart failure	14
CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells	14
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis	14
Targeting the Ca2+ signaling toolkit as an alternative strategy to mitigate SARS-CoV-2-induced cardiovascular adverse events	13
Editorial Board	12
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice	12
Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients	12
Sexual dimorphism in aortic aneurysm: A review of the contributions of sex hormones and sex chromosomes	12
Interplay between CD28 and PD-1 in T cell immunotherapy	12
Novel NLRP3 inflammasome inhibitors INF150 and INF195 attenuate isoproterenol-induced hypertrophy in H9c2 rat cardiac myoblast	12
Trimethylamine N-oxide (TMAO) impact on endothelial dysfunction: An in vitro study using bovine aortic endothelial cells	12
Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment	12
Graphical abstract TOC	12
Dynamic co-culture of endothelial and smooth muscle cells as a platform for pathophysiological investigations of vascular calcifications	12
Corrigendum to “Non-coding RNAs regulate angiogenic processes” [Vascular pharmacology 133–134 (2020) 106778]	12
The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis	12
Myocardial energy balance and metabolism as causes of myocardial ischemia	11
3-methoxycatechol causes vasodilation likely via KV channels: ex vivo, in silico docking and in vivo study	11
The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension	11
Editorial Board	10
Zinc alpha 2-glycoprotein associates with features of plaque stability in patients with carotid atherosclerosis	10
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment	10
The influence of environmental hypoxia on the goldfish (Carassius auratus) heart: From functional responses to mitochondrial molecular mechanisms	10
GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid	10
Graphical abstract TOC	10
Extracellular vesicles (EVs) in ischemic conditioning and angiogenesis: Focus on endothelial derived EVs	10
Inflammation and the pathogenesis of atherosclerosis	10
A treatment algorithm for ischemic cardiomyopathy	10
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human	10
Roles of endothelial and smooth muscle cell dysfunction and vasa vasorum in vasomotor disorders in ischemia with no obstructive coronary artery disease	10
Eighty years of oral anticoagulation: Learning from history	9
Immune response following transcatheter aortic valve procedure	9
Potency of miR-144-3p in promoting abdominal aortic aneurysm progression in mice correlates with apoptosis of smooth muscle cells	9
Relevance of real-time analyzers to determine mitochondrial quality in endothelial cells and oxidative stress in preeclampsia	9
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions	9
17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis	9
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)	9
Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction	9
Advancements in non-invasive hyperspectral imaging: Mapping blood oxygen levels and vascular health for clinical and research applications	9

Graphical abstract TOC	8
Contents continued	8
MELAS syndrome: Insights into cardiac mechanics	8
PI3KC2α: A novel key player in cardiac contractility and DOX-induced cardiotoxicity?	8
Plasma exosomes after PCI in non-diabetic STEMI patients fed barley beta-D-glucan-enriched pasta reduce oxidative stress-induced endothelial cell senescence	8
The selective deletion of tyrosyne hydroxylase gene in the endothelium affects cardiovascular function	8
Catestatin as a key attenuator of cardiac inflammation in hypertension: Role of macrophage immunosuppression	7
Extracellular stiffness as a determinant of cardiac dysfunction in Duchenne's muscular dystrophy: A study on human iPSC-derived cardiomyocytes	7
Prenatal exercise reprograms the development of hypertension progress and improves vascular health in SHR offspring	7
Stay connected: The myoendothelial junction proteins in vascular function and dysfunction	7
Amyloid-β: A potential mediator of aging-related vascular pathologies	7
Graphical abstract TOC	7
Melatonin treatment during chronic hypoxic gestation improves neonatal cerebrovascular function	7
Editorial Board	7
Effects of mavacamten in human myocardium from hypertrophic obstructive cardiomyopathy (HOCM) patients: A comparison with disopyramide	7
TLR4-Myd88 pathway upregulated caveolin-1 expression contributes to coronary artery spasm	7
Sodium nitroprusside for advanced heart failure. A metanalysis of literature data	7
Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice	7
Editorial Board	7
Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study	7
Is remote conditioning cardioprotection temperature dependent?	7
Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning	7
From cine-MRI to computational models of blood flow within the heart	7
Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??	7
Exploring bradykinin: A common mediator in the pathophysiology of sepsis and atherosclerotic cardiovascular disease	6
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study	6
Beta-blockers in pulmonary arterial hypertension: Time for a second thought?	6
Emerging therapies in dyslipidaemias	6
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: Dissecting the role of cardiac alternans in terminating rapid rhythms	6
Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles	6
The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-κB signaling	6
Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke	6
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging	6
Matrix metalloproteinases in aortic dissection	6
The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies	6
Graphical abstract TOC	6
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death	6
Macrophage-mediated downregulation of lncRNA Carmn in mouse abdominal aortic aneurysm	6
Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability	5
The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19	5
An intrinsic mechanism of metabolic resilience influences the cardiac response to stress	5
Graphical abstract TOC	5
An AI and Statistical Shape Analysis combined framework to extract features in complex cardiovascular structures	5
Tetrandrine promotes angiogenesis via transcriptional regulation of VEGF-A	5
Understanding the pathobiology of intermediate filaments to curb acute and chronic cardiac dysfunction	5
Different gene expression patterns between mouse and human brain pericytes revealed by single-cell/nucleus RNA sequencing	5
LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell	5
Editorial Board	5
Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats	5
Graphical abstract TOC	5
Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease	5
Palmitate-induced cardiac lipotoxicity is relieved by Quercetin and its novel acetylated derivative Q2 through inhibition of oxidative stress and inflammation	5
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage	5
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function	5
Contents continued	5
The crosstalk between lipopolysaccharide-induced septic myocardial dysfunction and cardiac lipotoxicity: Toll like receptor 4 as common target of the novel cardioprotective peptide cateslytin	5
Myocardin related transcription factor and galectin-3 drive lipid accumulation in human blood vessels	5
Emerging effects of non-coding RNA in vascular endothelial cells during strokes	5
Graphical abstract TOC	5